Ralliant Corporation (RAL): what the price assumes

In the published model solve dated 2026-Q2, anchored at $66.34, Ralliant Corporation (RAL) is priced for today's economics sustained for ~11.3 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-28.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/RAL

Headline

FieldValue
TickerRAL
CompanyRalliant Corporation
Current price$66.34/sh
CompositionDiversified electronics 19% / Communications 12% / Semiconductors 8% / Industrial manufacturing 21% / Defense and space 17% / Utilities 15% / Other 9%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Must persist for11.3y
Multiple paid32x operating income

Solve inputs: computed at a 11.8% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~2.1 years.

Reconcile: at the x-ray's 9.3% required return this reads ~6.5 years; the models below use their own rates.

How unusual the bet is: elevated

ReferenceValue
cohort percentile (of 187 peers)59
sustained it ~10 years at this level14%
implied end-window share0%

Valuation X-Ray

Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset5.41x3expensive
Earnings3.30x2expensive
Relative—0—
Growth0.92x3justifies

Families that justify the price: Growth Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.2%); the inversion above states its own rate.

Per-Model Detail (n=8)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$75.450.88xyesFCF base $0.3B, growth 8% (input: historical growth), terminal g 4.0%, WACC 8.2%, 6yr projection
DCF Exit MultipleGrowth$72.420.92xyesExit EV/EBITDA: 26.6x / 28.6x / 30.6x (bear / base = today's held flat / bull), 6yr
Relative ValuationRelative——noP/S fallback (negative EPS): Sector P/S 2.5x × TTM revenue — excluded from consensus
Simple DDMGrowth——no—
Two-Stage DDMGrowth——no—
Simple Excess ReturnAsset$13.624.87xyesReference only (book value floor): BV/sh $13.62, ROE negative
Two-Stage Excess ReturnAsset$12.265.41xyesReference only (book value with convergence): BV/sh $13.62, ROE converges to ke
Discounted Future Market CapGrowth$54.931.21xyesRev $1.6B, growth 8% (input: historical growth; tapered), Terminal P/S: 3.8x / 4.6x / 5.3x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$0.00—noNegative/zero EPS — earnings-based value floored at $0
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings$0.016634.00xyesNormalized EBIT (latest-period EBIT; under 3y history) $0.08B × (1−16%) / WACC 8.2% → EPV (no growth) (excluded from median)
Residual IncomeAsset——no—
Graham NumberAsset——no—
EV/EBITDA RelativeRelative——noEBITDA $0.29B × sector EV/EBITDA 12.0x
FCF YieldEarnings$23.672.80xyesFCF $327.7M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$17.483.80xyesSBC-adj FCF $0.26B (FCF $0.33B − SBC $0.06B) capitalized at Kₑ
Ben Graham FormulaEarnings——no—
ROIC-Justified P/BAsset$4.7613.94xyesBV $13.62 × (ROIC 2.8% / WACC 8.2%)
P/Sales SectorRelative——noRevenue $1.63B × sector P/S 2.5x
PEG Fair ValueRelative——no—
Earnings YieldEarnings——no—
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Economic-Unit Decomposition (Sum Of The Parts)

One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Test and Measurementoperatingenterprise0.8B reported-currency—withheldunresolved no unit value
Sensors and Safety Systemsoperatingenterprise1.3B reported-currency—withheldunresolved no unit value

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

FieldValue
Net debt$877.6m
Net debt / NOPAT (after-tax)4.02x
Net debt / operating income (pre-tax)3.36x
Share count CAGR (dilution)0.0%
Burning cashno

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

Ralliant is a precision-instruments company that spun out of Fortive at the end of June 2025, so its reported trailing numbers carry separation accounting and a short history. The clean read is the standalone quarter: revenue about $503 million, net earnings about $47.6 million, adjusted EBITDA margin near 20%. The business is profitable; the negative trailing figures in the data are spin distortion, not the operating reality.

On the model's frame the price looks rich, and even adjusting for the noise it is not cheap. At $68.16 the price embeds high, durable growth, and the methods that survive the spin distortion (exit-multiple DCF near $58, sector multiples in the $30 to $47 range) sit below the price. The reasonable-value band is well under the quote.

The two segments are diverging. Sensors and Safety Systems is seeing strong order demand from grid modernization and defense, while Test and Measurement volume is soft. The bet is on the sensors strength carrying a transition year.

Bull Case

What the standard valuation frame misses about Ralliant is that the numbers it is reading are not the business. Ralliant separated from Fortive on June 28, 2025, and began trading in late June, so the trailing financials in any automated screen are dominated by separation charges and combined-carve-out accounting rather than by how the standalone company actually operates. The reported trailing operating loss and negative margin are artifacts of that transition. The clean signal is the first standalone quarter: revenue of about $503 million, net earnings of about $47.6 million, GAAP EPS of $0.42, adjusted EPS of $0.67, and an adjusted EBITDA margin near 20%. This is a profitable, cash-generative precision-instruments business, not the money-loser the trailing line items suggest, and free cash flow of roughly $300 million confirms the underlying cash economics.

The franchise itself is a real, differentiated one. The company describes a Test and Measurement segment whose probes, source-measuring units, semiconductor test systems, high-power power supplies, and analysis software "empower scientists, engineers, and technicians" in advanced research and production (FY2025 10-K, accession 0002041385-26-000023). These are specialized, design-in products with installed-base economics, the kind of niche instrumentation that carries pricing power and recurring consumable and service attach. Spun out of Fortive, it inherits a continuous-improvement operating culture and a portfolio of category-leading brands.

The growth engine is the Sensors and Safety Systems segment, which is roughly 60% of revenue and is seeing strong order demand as customers invest in grid modernization and defense programs. Those are multi-year secular spending cycles, not freight-style cyclicals, and they give the larger segment a tailwind independent of the soft patch in Test and Measurement. Management has also launched a cost-savings program to address spin-related dis-synergies. For the bull, Ralliant is a quality instrumentation business at the messiest possible point in its reporting history, where the screen-level numbers understate the franchise and the standalone economics are only just becoming visible.

Bear Case

Even after you correct for the spin-off accounting, the model disagreement points the same way: the conservative methods say the price is full. Strip out the distorted trailing earnings and value the business on what it generates, and the methods that survive cluster well below the price. The exit-multiple DCF lands near $58, the sector EV/EBITDA method near $30, the price-to-sales method near $47, and the discounted-future-market-cap near $46, all under the $68 (June 28, 2026) quote. The reasonable-value band the model produces runs from roughly $13 to $24, and while the low end is exaggerated by the negative trailing inputs, the consistent message across the cleaner relative methods is that the price embeds a premium the current cash economics do not yet justify. The conservative methods are the more honest read precisely because the optimistic ones rely on extrapolating growth from a company with barely two quarters of standalone history.

The operating reality of the transition year is not flattering. First-quarter standalone results showed revenue down about 6% year over year, with net earnings margin off 260 basis points and adjusted EBITDA margin down 530 basis points, driven by lower volume in Test and Measurement, higher salaries and wages, the ramp-up of standalone public-company costs, and tariffs. A newly independent company absorbing dis-synergies and new corporate overhead, into a soft demand patch in its higher-technology segment, is the opposite of the smooth compounding the price assumes.

The structural risks compound the valuation risk. Net debt sits near $880 million, the company has no through-cycle operating-margin history to normalize against, and the short trading record means the market is pricing a franchise it has not yet seen perform across a full cycle independently. Test and Measurement, the more differentiated segment, is the one under volume pressure, and tariffs are a live cost headwind. The price needs the sensors strength and the cost program to more than offset all of that for years; if the Test and Measurement softness persists or the dis-synergies prove stickier than the $9 to $11 million savings target, the methods clustered in the $30s to $50s become the relevant anchor.

Valuation

The single most important thing to know before reading any number is that Ralliant spun out of Fortive at the end of June 2025, so the trailing operating income and margin in the data are dominated by separation accounting, not operations. The EDGAR trailing line shows a large operating loss while the record basis shows positive operating income, a divergence of well over 100%, which confirms the distortion. Treat the inversion multiple and the negative-margin frame as unreliable for this name; the standalone quarterly results (revenue about $503 million, net earnings about $47.6 million, adjusted EBITDA margin near 20%) are the honest economic picture.

With that caveat, the inversion reads the price as a long-duration growth bet (about 34 times distorted trailing operating income, implying the company holds a high growth pace for roughly 14 years), which the model flags as elevated. The more reliable signal is the cross-section of methods that do not depend on the distorted earnings line: the exit-multiple DCF near $58, sector EV/EBITDA near $30, price-to-sales near $47, and discounted-future-market-cap near $46. All sit below the $68 price. The asset and pure earnings methods are marked reference-only here because book value and trailing ROE are not meaningful through the spin.

The reconciliation: no valuation family reaches the price on the current (distorted and short-history) numbers, so the price is a bet that the standalone franchise compounds well beyond what the early standalone economics show. That is not implausible for a quality instrumentation business with a sensors tailwind, but it is a forward bet, not a value supported by today's cash generation. The balance sheet (net debt near $880 million, with no normalized margin to compute years-to-repay) adds a layer of uncertainty that a longer standalone track record will eventually resolve. Until then, the cleaner relative methods, not the price, are the better guide to value.

Catalysts

The defining event is the spin-off itself: Ralliant separated from Fortive on June 28, 2025, and began trading under RAL in late June. The most important near-term catalyst is simply the accumulation of clean standalone quarters that let the market value the business on its own economics rather than on transition accounting.

The segment trajectory is the key swing factor. Sensors and Safety Systems is seeing strong order demand from grid modernization and defense spending, multi-year secular cycles, while Test and Measurement volume has been soft. Each quarter's read on whether Test and Measurement stabilizes and whether the sensors order strength converts to revenue is the marker that matters most.

The self-help catalyst is the cost-savings program, initially targeting $9 to $11 million in annualized savings to offset spin-related Test and Measurement dis-synergies. Watch the realization against that target, along with two external headwinds management has flagged: tariffs and the ramp-up of standalone public-company costs. First standalone-quarter revenue was down about 6% year over year, so a return to growth is the demand-side catalyst to watch.

Sources: Ralliant Q2 2025 results (Ralliant investor relations, sec.gov 8-K), Fortive spin-off completion (Yahoo Finance), Seeking Alpha.

Peer Cohorts (Per Segment, With Filing Citations)

Test and Measurement (reported)

Sensors and Safety Systems (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

View the full interactive RAL report on boothcheck